
    
      This study evaluated non-inferiority about the efficacy and safety of γ-linolenic acid
      (Evoprim soft capsule) through patients with diabetic neuropathy were compared γ-linolenic
      acid (Evoprim soft capsule) and Thioctic acid(LipoA HR Tab. 600mg) using double-blind, double
      dummy clinical trials. First outcome measures are Visual Analog Scale(VAS) and Total Symptom
      Score(TSS), secondary outcome measures are Michigan Neuropathy Screening Instrument(MNSI),
      Current perception Threshold(CPT), Modified Brief Pain Inventory-diabetic
      polyneuropathy(Modified BPI-DPN) and EuroQol-5 Dimensions(EQ 5D).
    
  